(RC) Ready Capital - Overview
Stock: Commercial Loans, SBA Loans, Bridge Loans, Construction Loans, USDA Loans
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 9.01% |
| Yield on Cost 5y | 5.59% |
| Yield CAGR 5y | -30.60% |
| Payout Consistency | 86.5% |
| Payout Ratio | 91.3% |
| Risk 5d forecast | |
|---|---|
| Volatility | 45.3% |
| Relative Tail Risk | -0.89% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.98 |
| Alpha | -81.32 |
| Character TTM | |
|---|---|
| Beta | 0.931 |
| Beta Downside | 0.927 |
| Drawdowns 3y | |
|---|---|
| Max DD | 78.52% |
| CAGR/Max DD | -0.50 |
Description: RC Ready Capital December 25, 2025
Ready Capital Corp. (NYSE:RC) is a REIT-structured lender that focuses on lower-to-middle-market (LLM) commercial real-estate financing and SBA-guaranteed small-business loans. Its two operating segments are (1) LMM Commercial Real Estate, which originates and services construction, bridge, stabilized and agency loans across the full life-cycle of LLM properties, and (2) Small Business Lending, which originates, acquires and services owner-occupied SBA 7(a) loans, USDA loans and other small-business credit products. By electing REIT tax status, the firm must distribute at least 90 % of taxable income to shareholders, which underpins its historically high dividend yield.
Key recent metrics (Q3 2024): total loan portfolio ≈ $13.5 billion, with LLM CRE loans representing roughly 68 % and SBA/USDA loans the remaining 32 %; net interest margin stood at 4.3 % versus the sector median of 3.9 %; and the dividend yield was 7.6 % on a share price of ~$14. The business is sensitive to three macro drivers: (i) Federal Reserve policy-higher rates compress loan spreads and raise funding costs; (ii) CRE vacancy and rent-growth trends, especially in secondary markets where LLM assets are concentrated; and (iii) SBA loan demand, which rises in tighter credit cycles as borrowers seek government-backed financing.
If you want a deeper, data-driven view of RC’s valuation and risk profile, a quick look at ValueRay’s analyst toolkit can help you surface the most material assumptions.
Piotroski VR‑10 (Strict, 0-10) 2.5
| Net Income: -310.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA 4.51 > 1.0 |
| NWC/Revenue: -2097 % < 20% (prev -3494 %; Δ 1397 % < -1%) |
| CFO/TA 0.04 > 3% & CFO 366.2m > Net Income -310.9m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 0.20 > 1.5 & < 3 |
| Outstanding Shares: last quarter (167.8m) vs 12m ago -1.01% < -2% |
| Gross Margin: error (current vs previous; cannot be calculated due to missing/invalid data or negative margin) |
| Asset Turnover: 0.28% > 50% (prev 0.26%; Δ 0.02% > 0%) |
| Interest Coverage Ratio: -1.58 > 6 (EBITDA TTM -882.1m / Interest Expense TTM 557.2m) |
Altman Z'' -1.37
| A: -0.07 (Total Current Assets 147.5m - Total Current Liabilities 721.2m) / Total Assets 8.33b |
| B: -0.07 (Retained Earnings -569.7m / Total Assets 8.33b) |
| C: -0.09 (EBIT TTM -878.0m / Avg Total Assets 9.79b) |
| D: -0.09 (Book Value of Equity -593.8m / Total Liabilities 6.46b) |
| Altman-Z'' Score: -1.37 = CCC |
Beneish M -3.15
| DSRI: 1.02 (Receivables 322.6m/340.7m, Revenue 27.4m/29.3m) |
| GMI: 1.00 (fallback, negative margins) |
| AQI: 1.00 (AQ_t 0.98 / AQ_t-1 0.98) |
| SGI: 0.93 (Revenue 27.4m / 29.3m) |
| TATA: -0.08 (NI -310.9m - CFO 366.2m) / TA 8.33b) |
| Beneish M-Score: -3.15 (Cap -4..+1) = AA |
What is the price of RC shares?
Over the past week, the price has changed by -3.29%, over one month by +0.98%, over three months by -30.78% and over the past year by -66.52%.
Is RC a buy, sell or hold?
- StrongBuy: 0
- Buy: 0
- Hold: 7
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the RC price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 2.4 | 14.1% |
| Analysts Target Price | 2.4 | 14.1% |
| ValueRay Target Price | 1.6 | -24.8% |
RC Fundamental Data Overview February 03, 2026
P/S = 5.9123
P/B = 0.2154
Revenue TTM = 27.4m USD
EBIT TTM = -878.0m USD
EBITDA TTM = -882.1m USD
Long Term Debt = 3.35b USD (from longTermDebt, last quarter)
Short Term Debt = 418.2m USD (from shortTermDebt, last quarter)
Debt = 3.78b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.63b USD (from netDebt column, last quarter)
Enterprise Value = 3.98b USD (351.3m + Debt 3.78b - CCE 147.5m)
Interest Coverage Ratio = -1.58 (Ebit TTM -878.0m / Interest Expense TTM 557.2m)
EV/FCF = 10.87x (Enterprise Value 3.98b / FCF TTM 366.2m)
FCF Yield = 9.20% (FCF TTM 366.2m / Enterprise Value 3.98b)
FCF Margin = 1339 % (FCF TTM 366.2m / Revenue TTM 27.4m)
Net Margin = -1136 % (Net Income TTM -310.9m / Revenue TTM 27.4m)
Gross Margin = unknown ((Revenue TTM 27.4m - Cost of Revenue TTM 125.8m) / Revenue TTM)
Tobins Q-Ratio = 0.48 (Enterprise Value 3.98b / Total Assets 8.33b)
Interest Expense / Debt = 3.36% (Interest Expense 127.0m / Debt 3.78b)
Taxrate = 21.0% (US default 21%)
NOPAT = -693.6m (EBIT -878.0m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 0.20 (Total Current Assets 147.5m / Total Current Liabilities 721.2m)
Debt / Equity = 2.13 (Debt 3.78b / totalStockholderEquity, last quarter 1.77b)
Debt / EBITDA = -4.11 (negative EBITDA) (Net Debt 3.63b / EBITDA -882.1m)
Debt / FCF = 9.91 (Net Debt 3.63b / FCF TTM 366.2m)
Total Stockholder Equity = 1.85b (last 4 quarters mean from totalStockholderEquity)
RoA = -3.17% (Net Income -310.9m / Total Assets 8.33b)
RoE = -16.85% (Net Income TTM -310.9m / Total Stockholder Equity 1.85b)
RoCE = -16.90% (EBIT -878.0m / Capital Employed (Equity 1.85b + L.T.Debt 3.35b))
RoIC = -10.74% (negative operating profit) (NOPAT -693.6m / Invested Capital 6.46b)
WACC = 3.23% (E(351.3m)/V(4.13b) * Re(9.35%) + D(3.78b)/V(4.13b) * Rd(3.36%) * (1-Tc(0.21)))
Discount Rate = 9.35% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.26%
[DCF Debug] Terminal Value 80.82% ; FCFF base≈366.2m ; Y1≈240.4m ; Y5≈109.7m
Fair Price DCF = N/A (negative equity: EV 3.50b - Net Debt 3.63b = -134.5m; debt exceeds intrinsic value)
EPS Correlation: -88.87 | EPS CAGR: -21.98% | SUE: 0.39 | # QB: 0
Revenue Correlation: -56.92 | Revenue CAGR: -39.35% | SUE: -0.40 | # QB: 0
EPS next Quarter (2026-03-31): EPS=-0.05 | Chg30d=+0.001 | Revisions Net=+1 | Analysts=3
EPS next Year (2026-12-31): EPS=-0.02 | Chg30d=-0.058 | Revisions Net=+1 | Growth EPS=+97.9% | Growth Revenue=-10.9%